2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on AML: Is Ivosidenib + BCL2 Inhibitor Venetoclax +/- Azacitidine Effective for Patients With IDH1-Mutated AML?

199 views
July 22, 2020
Comments 0
Login to view comments. Click here to Login